Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-25

Clinical Trial Update: Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating selinexor with clarithromycin, pomalidomide, and dexamethasone for relapsed refractory multiple myeloma; study terminated with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Pomalidomide (Pomalidomide)
  • Selinexor (selinexor)
  • clarithromycin (clarithromycin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Myeloma Multiple, Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2023-10-25